Published on: 23 November 2021 Roche to present new pivotal data at ASH 2021 from broad and comprehensive portfolio, challenging treatment standards for people with blood disorders more
Published on: 19 November 2021 European Commission approves Roche’s Gavreto (pralsetinib) for the treatment of adults with RET fusion-positive advanced non-small cell lung cancer more
Latest annual report Highlights Annual Report 2020 How medicines are making an impact in the lives of patients more Annual Report 2020 Finance Report 2020 Roche in Brief 2020
